Australia Stock Exchange release from AVECHO BIOTECHNO : AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
19/12/2021 23:43
Australia Stock Exchange release from AVECHO BIOTECHNO AVE.AX : AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
Recent news on Avecho Biotechnology
See all newsBrief: Avecho Biotechnology Seeks Trading Halt
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
Brief: Avecho Biotechnology Seeks Trading Halt Pending Release Of Information About License And Development Agreement